The addition of doxazosin to the treatment regimen of patients with hypertension not adequately controlled by by β-blockers
Authors:
- 1 January 1991
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 121 (1) , 311-316
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Comparison of the effects of doxazosin and atenolol on blood pressure and blood lipids: A one-year, double-blind study in 228 hypertensive patientsAmerican Heart Journal, 1988
- Clinical experience with doxazosin in general medical practiceAmerican Heart Journal, 1988
- Doxazosin in patients with hypertensionEuropean Journal of Clinical Pharmacology, 1988
- On the combination of α- and β-adrenoceptor blockade in hypertensionClinical Pharmacology & Therapeutics, 1983
- Prazosin Update A Review of its Pharmacological Properties and Therapeutic Use in Hypertension and Congestive Heart FailureDrugs, 1983
- Antihypertensive agents which inhibit sympathetic activity: Potentially adverse effects of combination treatmentAmerican Heart Journal, 1982
- A pharmacodynamic and pharmacokinetic assessment of a new alpha‐ adrenoceptor antagonist, doxazosin (UK33274) in normotensive subjects.British Journal of Clinical Pharmacology, 1982
- α-Adrenoceptor Blockade by Phentolamine Causes β-Adrenergic Vasodilation by Increased Catecholamine Release Due to Presynaptic α-BlockadeJournal of Cardiovascular Pharmacology, 1982
- Haemodynamic Changes in Hypertension and Their Modification by β-Blockers and PrazosinJournal of Cardiovascular Pharmacology, 1980
- Comparative haemodynamic effects of labetalol, timolol, prazosin and the combination of tolamolol and prazosin.British Journal of Clinical Pharmacology, 1979